GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hunan Dajiaweikang Pharmaceutical Industry Co Ltd (SZSE:301126) » Definitions » Total Equity

Hunan Dajiaweikang Pharmaceutical Industry Co (SZSE:301126) Total Equity : ¥1,833 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hunan Dajiaweikang Pharmaceutical Industry Co Total Equity?

Hunan Dajiaweikang Pharmaceutical Industry Co's total equity for the quarter that ended in Mar. 2024 was ¥1,833 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Hunan Dajiaweikang Pharmaceutical Industry Co Total Equity Historical Data

The historical data trend for Hunan Dajiaweikang Pharmaceutical Industry Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Dajiaweikang Pharmaceutical Industry Co Total Equity Chart

Hunan Dajiaweikang Pharmaceutical Industry Co Annual Data
Trend Dec12 Dec13 Dec14 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 977.24 1,041.42 1,679.14 1,817.23 1,781.65

Hunan Dajiaweikang Pharmaceutical Industry Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,845.61 1,844.28 1,803.13 1,781.65 1,832.57

Hunan Dajiaweikang Pharmaceutical Industry Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Hunan Dajiaweikang Pharmaceutical Industry Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=5277.655-3496.006
=1,782

Hunan Dajiaweikang Pharmaceutical Industry Co's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=6047.54-4214.968
=1,833

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Dajiaweikang Pharmaceutical Industry Co Total Equity Related Terms

Thank you for viewing the detailed overview of Hunan Dajiaweikang Pharmaceutical Industry Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Dajiaweikang Pharmaceutical Industry Co (SZSE:301126) Business Description

Traded in Other Exchanges
N/A
Address
No. 30 Fuling Road, Yuelu District, Hunan Province, Changsha, CHN, 410000
Hunan Dajiaweikang Pharmaceutical Industry Co Ltd is engaged in the distribution and retail of pharmaceuticals, biological products, medical equipment and other products.
Executives
Tang Juan Supervisors
Zhong Xue Song Director

Hunan Dajiaweikang Pharmaceutical Industry Co (SZSE:301126) Headlines

No Headlines